6550-12-388-3829
Standard Buffer Solution
6550123883829 123883829 04 880 340 190
A compound, formulated to a specific pH value that tends to resist change in pH when moderate amounts of either a base or acid are added, or on dilution with a solvent. View more Standard Buffer Solution
![]()
Managed by Germany
NSN Created on 15 Mar 2012
Data Last Changed
January 2023
January 2023
NATO Update Count
1
1
NATO Data Quality

Marketplace 6550-12-388-3829
Need Help?
Request a Quotation from participating marketplace vendors
Request a Quotation from participating marketplace vendors
Related Documents 6550-12-388-3829 3+ Documents (More...)
https//www.nsnlookup.com
/fsg-65/fsc-6550/de
/fsg-65/fsc-6550/de
6550-12-388-3829 Standard Buffer Solution 6550123883829
RQST NE Updated Every Day 6550-12-388-3829 RQST Updated Every Day 6550-12-388-3829 RQST NE Related Documents
6550-12-388-3829 3+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6550/de 6550-12-388-3829
Standard Buffer Solution 6550123883829 RQST NE Updated Every Day 6550-12-388-3829 RQST Updated Every
6550-12-388-3829 3+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6550/de 6550-12-388-3829
Standard Buffer Solution 6550123883829 RQST NE Updated Every Day 6550-12-388-3829 RQST Updated Every
CharacteristicSpecificationsFIIGA23900Special Features [FEAT]Human Anti-Gliadin Iga https//www.nsnlookup.com /fsg-65/fsc-6550/de 6550-12-388-3829
Standard Buffer Solution 6550123883829 Documents ( More... ) https//www.nsnlookup.com https//www.nsnlookup.com
Standard Buffer Solution 6550123883829 Documents ( More... ) https//www.nsnlookup.com https//www.nsnlookup.com
RNCC: 3 | RNVC: 2 1661850 RNCC: 5 | RNVC: 9 HARNSAEUREPLUSSYS1 RNCC: 5 | RNVC: 9 10 May 2006 6550-12-388-3829
Restrictions 6550-12-388-3829
End Users 6550-12-388-3829
- Belgium (ZB)
Approved Sources 6550-12-388-3829
- Part Number
- Manufacturer
- Status
- 04 880 340 190
- Manufacturer
- D8231 - Roche Diagnostics Gmbh (Active)
- Primary Buy
- Primary Buy
Similar Supply Items to 6550-12-388-3829

















